ARTICLE | Company News
Grifols partners with Alkahest, takes equity stake
March 5, 2015 1:52 AM UTC
Grifols S.A. (Madrid:GRF; NASDAQ:GRFS) and Alkahest Inc. will collaborate to develop plasma-based therapies to treat cognitive decline in aging and CNS disorders.
Grifols will acquire a 45% stake in Alkahest for $37.5 million in cash, and will receive worldwide commercialization rights to plasma-based CNS products. Alkahest will also receive a $12.5 million payment and research funding, and will be eligible for undisclosed milestones and royalties. ...